Follow
Zoltán Papp
Zoltán Papp
University of Debrecen, Department of Cardiology, Division of Clinical Physiology
Verified email at med.unideb.hu
Title
Cited by
Cited by
Year
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the …
K Sliwa, D Hilfiker-Kleiner, MC Petrie, A Mebazaa, B Pieske, E Buchmann, ...
European journal of heart failure 12 (8), 767-778, 2010
13312010
Cardiomyocyte stiffness in diastolic heart failure
A Borbély, J Van Der Velden, Z Papp, JGF Bronzwaer, I Edes, ...
Circulation 111 (6), 774-781, 2005
7062005
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain
A Tóth, J Boczán, N Kedei, E Lizanecz, Z Bagi, Z Papp, I Édes, L Csiba, ...
Molecular Brain Research 135 (1-2), 162-168, 2005
5282005
Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium
A Borbély, I Falcao-Pires, L van Heerebeek, N Hamdani, I Edes, C Gavina, ...
Circulation research 104 (6), 780-786, 2009
4472009
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan
Z Papp, I Édes, S Fruhwald, SG De Hert, M Salmenperä, H Leppikangas, ...
International journal of cardiology 159 (2), 82-87, 2012
3982012
Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the …
VP Harjola, W Mullens, M Banaszewski, J Bauersachs, ...
European journal of heart failure 19 (7), 821-836, 2017
3862017
Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins
J van der Velden, Z Papp, R Zaremba, NM Boontje, JW de Jong, VJ Owen, ...
Cardiovascular research 57 (1), 37-47, 2003
3602003
The continuous heart failure spectrum: moving beyond an ejection fraction classification
F Triposkiadis, J Butler, FM Abboud, PW Armstrong, S Adamopoulos, ...
European heart journal 40 (26), 2155-2163, 2019
2682019
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and …
D Kolijn, S Pabel, Y Tian, M Lódi, M Herwig, A Carrizzo, S Zhazykbayeva, ...
Cardiovascular research 117 (2), 495-507, 2021
2592021
Treatments targeting inotropy: a position paper of the Committees on Translational Research and Acute Heart Failure of the Heart Failure Association of the European Society of …
C Maack, T Eschenhagen, N Hamdani, FR Heinzel, AR Lyon, ...
European heart journal 40 (44), 3626-3644, 2019
2052019
Pharmacological mechanisms contributing to the clinical efficacy of levosimendan
Z Papp, K Csapó, P Pollesello, H Haikala, I Édes
Cardiovascular drug reviews 23 (1), 71-98, 2005
1872005
The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig
S Szilágyi, P Pollesello, J Levijoki, P Kaheinen, H Haikala, I Édes, Z Papp
European journal of pharmacology 486 (1), 67-74, 2004
1712004
Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1
T Kark, Z Bagi, E Lizanecz, ET Pásztor, N Erdei, Á Czikora, Z Papp, I Édes, ...
Molecular pharmacology 73 (5), 1405-1412, 2008
1602008
The cardioprotective effects of levosimendan: preclinical and clinical evidence
P Pollesello, Z Papp
Journal of cardiovascular pharmacology 50 (3), 257-263, 2007
1572007
The effect of myosin light chain 2 dephosphorylation on Ca2+-sensitivity of force is enhanced in failing human hearts
J van der Velden, Z Papp, NM Boontje, R Zaremba, JW de Jong, ...
Cardiovascular research 57 (2), 505-514, 2003
1572003
Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper
D Farmakis, J Alvarez, TB Gal, D Brito, F Fedele, C Fonseca, AC Gordon, ...
International Journal of Cardiology 222, 303-312, 2016
1532016
Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use
Z Papp, P Agostoni, J Alvarez, D Bettex, S Bouchez, D Brito, V Černý, ...
Journal of cardiovascular pharmacology 76 (1), 4-22, 2020
1492020
High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion
N Erdei, A Tóth, ET Pásztor, Z Papp, I Edes, A Koller, Z Bagi
American journal of physiology-heart and circulatory physiology 291 (5 …, 2006
1372006
The levosimendan metabolite OR‐1896 elicits vasodilation by activating the KATP and BKCa channels in rat isolated arterioles
N Erdei, Z Papp, P Pollesello, I Édes, Z Bagi
British journal of pharmacology 148 (5), 696-702, 2006
1252006
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in …
PM Seferović, S Stoerk, G Filippatos, V Mareev, A Kavoliuniene, AD Ristić, ...
European journal of heart failure 15 (9), 947-959, 2013
1172013
The system can't perform the operation now. Try again later.
Articles 1–20